About Daisy Genomics
What Sets Us Apart
Our pioneering technology aims to address significant gaps in genomic research, diagnostics, and therapeutics, particularly by identifying the areas of the genome that are unseen today.
At the heart of our company's differentiation is our pioneering direct optical long-read sequencing approach. This revolutionary method combines cutting-edge nanofluidic processes with optics to unearth an unprecedented level of genomic information.
Our Team
CEO Emily Milsovic
FOUNDER & CSO Steve Brueck
BOARD OF DIRECTORS Todd Dickinson
BOARD OF DIRECTORS David Blivin
BOARD OF DIRECTORS Waneta Tuttle
Lead Scientific Advisor Charles Cantor, PhD
